According to Medifast's latest financial reports the company's total assets are $0.30 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.30 B | -1.99% |
2022-12-31 | $0.31 B | -20.61% |
2021-12-31 | $0.39 B | 44.28% |
2020-12-31 | $0.27 B | 41.83% |
2019-12-31 | $0.19 B | 14.89% |
2018-12-31 | $0.16 B | 16.1% |
2017-12-31 | $0.14 B | 20.39% |
2016-12-31 | $0.12 B | 4.39% |
2015-12-31 | $0.11 B | 0.18% |
2014-12-31 | $0.11 B | -12.62% |
2013-12-31 | $0.13 B | 1.84% |
2012-12-31 | $0.13 B | 23.27% |
2011-12-31 | $0.10 B | 12.34% |
2010-12-31 | $94.05 M | 49.39% |
2009-12-31 | $62.96 M | 25.13% |
2008-12-31 | $50.31 M | 15.08% |
2007-12-31 | $43.72 M | 19.21% |
2006-12-31 | $36.67 M | 20.08% |
2005-12-31 | $30.54 M | 17.63% |
2004-12-31 | $25.96 M | 7.16% |
2003-12-31 | $24.23 M | 145.06% |
2002-12-31 | $9.88 M | 194.55% |
2001-12-31 | $3.35 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $2.01 B | 549.13% | ๐บ๐ธ USA |
Abeona Therapeutics
ABEO | $64 M | -79.35% | ๐บ๐ธ USA |
Bellerophon Therapeutics
BLPH | $4.97 M | -98.39% | ๐บ๐ธ USA |